Trade

with

Varian Medical Systems Inc
(NYSE: VAR)
US Markets Closed
AdChoices
81.84
+1.49
+1.85%
After Hours :
81.84
0.00
0.00%

Open

81.08

Previous Close

80.35

Volume (Avg)

848.54k (670.56k)

Day's Range

80.93-81.99

52Wk Range

71.98-87.85

Market Cap.

8.45B

Dividend Rate ( Yield )

-

Beta

0.91

Shares Outstanding

103.20M

P/E Ratio (EPS)

21.01 (3.89)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Medical Devices
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 2.94B

    • Net Income

    • 438.25M

    • Market Cap.

    • 8.45B

    • Enterprise Value

    • 7.79B

    • Net Profit Margin %

    • 13.80

    • PEG (Price/Earnings Growth) Ratio

    • 1.51

    • Beta

    • 0.91

    • Forward P/E

    • 17.06

    • Price/Sales

    • 2.90

    • Price/Book Value

    • 4.93

    • Price/Cash flow

    • 20.62

      • EBITDA

      • 679.07M

      • Return on Capital %

      • 12.71

      • Return on Equity %

      • 24.43

      • Return on Assets %

      • 12.71

      • Book Value/Share

      • 16.62

      • Shares Outstanding

      • 103.20M

      • Last Split Factor (Date)

      • 2:1 (8/2/2004)

      • Last Dividend (Ex-Date)

      • 0.01 (12/2/1998)

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/20/2014
      Buy
        • 1 Year Price Target

        • 95.00

        • Credit Rating

        • -

        • Analysts

        • 5

        • EPS Estimate

        • 4.75

        • Cashflow Estimate

        • 5.86

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 3.00

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • 2.60

          • -22.64

          • Net Income

            Q/Q (last year)

          • -5.10

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • 7.29

          • 4.60

          • Net Income

            5-Year Annual Average

          • 8.20

          • -1.34

          • Dividends

            5-Year Annual Average

          • -

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 42.89

            • 64.08

            • Pre-Tax Margin

            • 19.15

            • 15.19

            • Net Profit Margin

            • 13.80

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • 43.10

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 21.80

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • 15.00

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.23

              • 0.34

              • Current Ratio

              • 2.17

              • 2.55

              • Quick Ratio

              • 1.43

              • 1.83

              • Interest Coverage

              • 84.51

              • 11.70

              • Leverage Ratio

              • 2.03

              • 1.86

              • Book Value/Share

              • 16.62

              • 11.69

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 20.37

                • 34.01

                • P/E Ratio 5-Year High

                • 22.56

                • 224.03

                • P/E Ratio 5-Year Low

                • 9.12

                • 60.23

                • Price/Sales Ratio

                • 2.81

                • 3.17

                • Price/Book Value

                • 4.78

                • 3.20

                • Price/Cash Flow Ratio

                • 20.62

                • 18.42

                • Key Metrics

                • Company

                  • Shares Short

                    as of 9/30/2014

                  • 5.66M

                  • Short Ratio

                    as of 9/30/2014

                  • 9.10

                  • Short % of Float

                    as of 9/30/2014

                  • 5.39

                  • Shares Short

                    prior month

                  • 5.63M

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • 0.00

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • 12/2/1998

                    • Last Split Factor

                      new per old

                    • 2:1

                    • Last Split Date

                    • 8/2/2004

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 24.43

                        (29.00)

                      • 12.33

                        (18.16)

                      • Return on Assets %

                        (5-Year Average)

                      • 12.71

                        (15.30)

                      • 6.62

                        (8.69)

                      • Return on Capital %

                        (5-Year Average)

                      • 20.74

                        (26.30)

                      • 8.49

                        (11.48)

                      • Income/Employee

                      • 64.87k

                      • 34.11k

                      • Inventory Turnover

                      • 3.06

                      • 2.77

                      • Asset Turnover

                      • 0.92

                      • 0.51

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      608.89M
                      Operating Margin
                      20.69
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      20.62
                      Ownership

                      Institutional Ownership

                      97.87%

                      Top 10 Institutions

                      33.08%

                      Mutual Fund Ownership

                      49.00%

                      Float

                      99.73%

                      5% / Insider Ownership

                      0.32%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Mid-Cap Index Fund

                      •  

                        1,765,606

                      • 0.37

                      • 1.71

                      • Vanguard Total Stock Mkt Idx

                      •  

                        1,696,790

                      • 0.63

                      • 1.64

                      • Jensen Quality Growth Fund

                      •  

                        1,594,000

                      • 0.00

                      • 1.54

                      • ASTON/Fairpointe Mid Cap Fund

                      •  

                        1,570,300

                      • -0.57

                      • 1.52

                      • Old Westbury Small & Mid Cap Fund

                      •  

                        1,470,000

                      • -10.64

                      • 1.42

                      • Ivy Mid Cap Growth Fund

                      •  

                        1,288,050

                      • 1.22

                      • 1.25

                      • AZ InvestEd Ivy Mid Cap Growth Fund

                      •  

                        1,272,500

                      • 4.13

                      • 1.22

                      • Harris Assoc. Equity & Income Strategy

                      •  

                        1,210,401

                      • -12.90

                      • 1.17

                      • Oakmark Equity and Income Fund

                      •  

                        1,210,401

                      • -12.90

                      • 1.17

                      • Vanguard Five Hundred Index Fund

                      •  

                        1,071,367

                      • -0.50

                      • 1.04

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Group, Inc.

                      •  

                        7,334,233

                      • +1.39%

                      • 7.11

                      • State Street Corp

                      •  

                        4,256,837

                      • +0.35%

                      • 4.13

                      • Generation Investment Management LLP

                      •  

                        3,996,183

                      • +2.71%

                      • 3.87

                      • BlackRock Fund Advisors

                      •  

                        3,103,845

                      • +0.13%

                      • 3.01

                      • Loomis Sayles & Company L.P.

                      •  

                        3,056,906

                      • +6.60%

                      • 2.96

                      • Veritas Asset Management LLP

                      •  

                        3,052,107

                      • +2.09%

                      • 2.96

                      • Wedgewood Partners, Inc.

                      •  

                        2,601,412

                      • +5.96%

                      • 2.52

                      • Janus Capital Management LLC

                      •  

                        2,414,605

                      • -7.10%

                      • 2.34

                      • Waddell & Reed Investment Management Co

                      •  

                        2,214,911

                      • +1.99%

                      • 2.15

                      • Fairpointe Capital LLC

                      •  

                        2,094,656

                      • -3.03%

                      • 2.03

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Medical Devices

                      Type

                      Classic Growth

                      Style

                      Mid Core

                      Varian Medical Systems Inc is a Delaware corporation was originally incorporated in 1948 as Varian Associates, Inc. The Company is a manufacturer of medical devices and software for treating cancer and other medical conditions with r...moreadiotherapy, radiosurgery, proton therapy and brachytherapy. It is a supplier of x-ray imaging components for medical, scientific, and industrial applications and also supplies x-ray imaging products for cargo screening and industrial inspection. The Company has two reportable operating segments: Oncology Systems and X-ray Products. The Oncology Systems business segment designs, manufactures, sells and services hardware and software products for treating cancer with radiotherapy, stereotactic radiotherapy, stereotactic body radiotherapy, stereotactic radiosurgery and bra...morechytherapy. Products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment and accessories; as well as information management, treatment planning and image processing software. Oncology Systems products enable radiation oncology departments in hospitals and clinics to perform conventional radiotherapy treatments and offer advanced treatments such as fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy and stereotactic radiotherapy, as well as to treat patients using brachytherapy techniques, which involve temporarily implanting radioactive sources. The Companys Oncology Systems products are also used by neurosurgeons to perform stereotactic radiosurgery. Oncology Systems customers worldwide include university research and community hospitals, private and governmental institutions, healthcare agencies, physicians offices and cancer care clinics. The X-ray Products business segment designs, manufactures, sells and services x-ray imaging components for use in a range of applications, including radiographic or fluoroscopic imaging, mammography, special procedures, computed tomography and industrial applications. The Companys x-ray imaging components are sold to large imaging system OEM customers that incorporate them into their medical diagnostic, dental, veterinary and industrial imaging systems. It sells x-ray tubes and flat panel digital image detectors for filmless x-ray imaging to small OEMs, independent service companies and directly to end-users for replacement purposes. The Company has three other businesses that are reported together under the Other category. SIP designs, manufactures, sells and services Linatron® x-ray accelerators, imaging processing software and image detection products for security and inspection purposes, such as cargo screening at ports and borders and nondestructive examination in a variety of applications. The VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, a form of external beam radiotherapy using proton beams for the treatment of cancer. GTC develops technologies that enhance the Companys current businesses to new business areas, including technology to improve radiation therapy and x-ray imaging, as well as other technology for a variety of applications, including security and cargo screening. Its main competitors are Elekta AB and Accuray, Philips Medical Systems, RaySearch Laboratories AB, Brainlab AG and Best Theratronics, Ltd, MIM Software Inc. and Eckert & Ziegler BEBIG GmbH. The Company is subject to federal, state and local laws and regulations on an array of additional subjects.lessless

                      Key People

                      Mr. Dow R. Wilson

                      CEO/Director/President

                      R. Andrew Eckert

                      Chairman of the Board/Director

                      Timothy E. Guertin

                      Director/Vice Chairman of the Board

                      Ms. Elisha W. Finney

                      CFO/Executive VP, Divisional

                      Susan L. Bostrom

                      Director

                      • Varian Medical Systems Inc

                      • 3100 Hansen Way

                      • Palo Alto, CA 94304-1030

                      • USA.Map

                      • Phone: +1 650 493-4000

                      • Fax: -

                      • varian.com

                      Incorporated

                      1948

                      Employees

                      6,400

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: